An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype

Although clinical features, cytogenetics, and mutations are widely used to predict prognosis in patients with acute myeloid leukemia (AML), further refinement of risk stratification is necessary for optimal treatment, especially in cytogenetically normal (CN) patients. We sought to generate a simple...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Ming-Kai, Chiu, Yu-Chiao, Chou, Wen-Chien, Hou, Hsin-An, Tseng, Mei-Hsuan, Kuo, Yi-Yi, Chen, Yidong, Chuang, Eric Y., Tien, Hwei-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770759/
https://www.ncbi.nlm.nih.gov/pubmed/26517675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770759/
https://www.ncbi.nlm.nih.gov/pubmed/26517675

Ejemplares similares